1 – 62 of 62
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Educational attainment in survivors of childhood cancer in Denmark, Finland, and Sweden
(
- Contribution to journal › Article
-
Mark
Body mass index, triglyceride-glucose index, and prostate cancer death : a mediation analysis in eight European cohorts
(
- Contribution to journal › Article
-
Mark
Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe : the PanCareSurFup study
2024) In British Journal of Cancer(
- Contribution to journal › Article
-
Mark
Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer : a multicentre external validation in patients who underwent surgery
2024) In British Journal of Cancer(
- Contribution to journal › Article
-
Mark
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial
(
- Contribution to journal › Article
- 2023
-
Mark
Dietary intake of total, heme and non-heme iron and the risk of colorectal cancer in a European prospective cohort study
(
- Contribution to journal › Article
-
Mark
Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe : the PanCareSurFup study
(
- Contribution to journal › Article
-
Mark
Side effects of low-dose tamoxifen : results from a six-armed randomised controlled trial in healthy women
(
- Contribution to journal › Article
-
Mark
Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms
(
- Contribution to journal › Article
-
Mark
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
(
- Contribution to journal › Article
- 2022
-
Mark
High PGD2 receptor 2 levels are associated with poor prognosis in colorectal cancer patients and induce VEGF expression in colon cancer cells and migration in a zebrafish xenograft model
(
- Contribution to journal › Article
-
Mark
Patient trajectories after diagnosis of diffuse large B-cell lymphoma—a multistate modelling approach to estimate the chance of lasting remission
(
- Contribution to journal › Article
-
Mark
Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer
(
- Contribution to journal › Article
-
Mark
Independent validation of a pre-specified four-kallikrein marker model for prediction of adverse pathology and biochemical recurrence
(
- Contribution to journal › Article
- 2021
-
Mark
Mendelian randomisation study of smoking exposure in relation to breast cancer risk
(
- Contribution to journal › Article
- 2020
-
Mark
Breast cancer survival in Nordic BRCA2 mutation carriers—unconventional association with oestrogen receptor status
(
- Contribution to journal › Article
-
Mark
A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy
(
- Contribution to journal › Article
- 2018
-
Mark
A minority-group of renal cell cancer patients with high infiltration of CD20+B-cells is associated with poor prognosis
(
- Contribution to journal › Article
-
Mark
Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases
(
- Contribution to journal › Article
-
Mark
Immune gene expression and response to chemotherapy in advanced breast cancer
(
- Contribution to journal › Article
-
Mark
Excess body weight, weight gain and obesity-related cancer risk in women in Norway : the Norwegian Women and Cancer study
(
- Contribution to journal › Article
- 2017
-
Mark
Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer : A phase III, randomised, multicentre trial (Ovaresist)
(
- Contribution to journal › Article
-
Mark
Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma
(
- Contribution to journal › Article
-
Mark
Towards gene-and gender-based risk estimates in Lynch syndrome; Age-specific incidences for 13 extra-colorectal cancer types
(
- Contribution to journal › Article
-
Mark
Mediterranean diet and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition cohort
(
- Contribution to journal › Article
-
Mark
SLUG transcription factor : A pro-survival and prognostic factor in gastrointestinal stromal tumour
(
- Contribution to journal › Article
- 2016
-
Mark
Fast-track access to urologic care for patients with macroscopic haematuria is efficient and cost-effective : results from a prospective intervention study
(
- Contribution to journal › Article
-
Mark
Main nutrient patterns and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition study
(
- Contribution to journal › Article
-
Mark
Extracellular matrix composition defines an ultra-high-risk group of neuroblastoma within the high-risk patient cohort
(
- Contribution to journal › Article
-
Mark
Impacts of smoking on endocrine treatment response in a prospective breast cancer cohort
(
- Contribution to journal › Article
-
Mark
Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer
(
- Contribution to journal › Article
- 2015
-
Mark
An analysis of the association between prostate cancer risk loci, PSA levels, disease aggressiveness and disease-specific mortality
(
- Contribution to journal › Article
- 2008
-
Mark
Health-related quality of life and distress in cancer patients: results from a large randomised study
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2007
-
Mark
Familial risk for gastric carcinoma : An updated study from Sweden
(
- Contribution to journal › Article
- 2006
-
Mark
The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4 : a study in bladder cancer patients
(
- Contribution to journal › Article
- 2005
-
Mark
Occupation and bladder cancer : A cohort study in Sweden
(
- Contribution to journal › Article
-
Mark
Second primary malignancies in patients with male breast cancer
(
- Contribution to journal › Article
-
Mark
Tobacco smoking, snuff dipping and the risk of cutaneous squamous cell carcinoma : a nationwide cohort study in Sweden
(
- Contribution to journal › Article
- 2004
-
Mark
Familial risk in testicular cancer as a clue to a heritable and environmental aetiology
(
- Contribution to journal › Article
-
Mark
Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients
(
- Contribution to journal › Article
- 2002
-
Mark
Cancer risks in childhood and adolescence among the offspring of immigrants to Sweden
(
- Contribution to journal › Article
- 2001
-
Mark
A population-based cohort study of HRT use and breast cancer in southern Sweden
(
- Contribution to journal › Article
-
Mark
Familial colorectal adenocarcinoma and hereditary nonpolyposis colorectal cancer : a nationwide epidemiological study from Sweden
(
- Contribution to journal › Article
- 2000
-
Mark
Risk of cutaneous malignant melanoma in relation to use of sunbeds : further evidence for UV-A carcinogenicity
(
- Contribution to journal › Article
-
Mark
Cancers in the first-degree relatives of children with brain tumours
(
- Contribution to journal › Article
- 1999
-
Mark
CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk
(
- Contribution to journal › Article
- 1998
-
Mark
Comparison between interstitial laser thermotherapy and excision of an adenocarcinoma transplanted into rat liver
(
- Contribution to journal › Article
- 1997
-
Mark
A segregation analysis of testicular cancer based on Norwegian and Swedish families
(
- Contribution to journal › Article
- 1996
-
Mark
Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer
(
- Contribution to journal › Article
-
Mark
Blood transfusion as a risk factor for non-Hodgkin lymphoma
(
- Contribution to journal › Article
-
Mark
Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factors
(
- Contribution to journal › Article
-
Mark
Risk of cancer in relatives of testicular cancer patients
(
- Contribution to journal › Article
-
Mark
Familial testicular cancer in Norway and southern Sweden
(
- Contribution to journal › Article
-
Mark
A non-random deletion in the p53 gene in oral squamous cell carcinoma
(
- Contribution to journal › Article
- 1994
-
Mark
Cancer morbidity in alcohol abusers
(
- Contribution to journal › Article
- 1991
-
Mark
Association of int2/hst1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis
(
- Contribution to journal › Article
- 1990
-
Mark
Rising incidence of breast cancer among young women in Sweden
(
- Contribution to journal › Article
- 1989
-
Mark
Breast cancer and the pill
(
- Contribution to journal › Letter
- 1987
-
Mark
Mitotic activity in non-Hodgkinʹs lymphoma. Relation to the kiel classification and to prognosis
(
- Contribution to journal › Article
- 1986
-
Mark
On cohort effects in studies on oral contraceptive use and breast cancer
(
- Contribution to journal › Letter
- 1981
-
Mark
Malignant lymphoma and exposure to chemicals, especially organic solvents, chlorophenols and phenoxy acids : A case-control study
(
- Contribution to journal › Article